ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 120 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $157,448 | -89.4% | 51,963 | -91.9% | 0.01% | -92.9% |
| Q4 2022 | $1,491,137 | +1654.3% | 639,973 | +1346.3% | 0.07% | +2233.3% |
| Q3 2022 | $85,000 | -33.1% | 44,250 | -5.8% | 0.00% | -25.0% |
| Q2 2022 | $127,000 | +4.1% | 46,988 | +14.5% | 0.00% | +100.0% |
| Q1 2022 | $122,000 | -23.3% | 41,031 | +0.2% | 0.00% | -33.3% |
| Q4 2021 | $159,000 | +2.6% | 40,934 | +13.1% | 0.00% | 0.0% |
| Q3 2021 | $155,000 | +72.2% | 36,207 | +27.3% | 0.00% | +200.0% |
| Q2 2021 | $90,000 | +9.8% | 28,451 | +9.4% | 0.00% | 0.0% |
| Q1 2021 | $82,000 | -46.8% | 26,009 | -37.0% | 0.00% | -66.7% |
| Q4 2020 | $154,000 | +6.9% | 41,299 | -9.0% | 0.00% | -40.0% |
| Q3 2020 | $144,000 | +269.2% | 45,373 | +121.1% | 0.01% | +400.0% |
| Q2 2020 | $39,000 | – | 20,520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |